BCP
CLBT icon

Balance Capital Partners’s Cellebrite CLBT Stock Holding History

Balance Capital Partners’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-105,279
Closed -$1.45M – 11
2026
Q1 		$1.45M Hold
105,279
– – 1.65% 6
2025
Q4 		$1.9M Buy
+105,279
New +$1.89M 1.54% 3

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Balance Capital Partners's CLBT Position: Q2 2026 in Review

Balance Capital Partners sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 105,279 shares — an estimated $1.45M sold.

Balance Capital Partners first reported a position in CLBT in Q4 2025 and held it in 2 quarters. The position peaked at $1.9M in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Balance Capital Partners reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Balance Capital Partners sold 105,279 Cellebrite shares in Q2 2026, an estimated $1.45M.
  • Balance Capital Partners first reported a position in Cellebrite in Q4 2025 and held it in 2 quarters.
  • Balance Capital Partners's Cellebrite position peaked at $1.9M in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Balance Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.